More News

21 Apr 2020 Esperion Announces Agreement with Otsuka Pharmaceutical Co., Ltd. for Development and Commercialization of NEXLETOL™ (bempedoic acid) and NEXLIZET™ (bempedoic acid and ezetimibe) Tablets in Japan
20 Apr 2020 COVID-19: 155 drugs and 79 vaccines under development worldwide
17 Apr 2020 Kubota Vision Announces Signing of Open Innovation Agreement with LEO Pharma A/S to Screen Novel VAP-1 Inhibitor Compounds for Inflammatory Skin Diseases
17 Apr 2020 LegoChem Biosciences and Iksuda Enter into a Multi-Target Research Collaboration and License Agreement for the Development of Antibody-Drug Conjugates
16 Apr 2020 Galapagos and Ryvu Announce Research Collaboration
15 Apr 2020 Y-mAbs enters into Worldwide Exclusive License Agreement for SADA Technology – a Novel Radioimmunotherapy Platform
15 Apr 2020 LEO Pharma Enters License Agreement with Oneness Biotech and Microbio Shanghai for FB825 a Novel Atopic Dermatitis and Asthma Drug Candidate
15 Apr 2020 TScan Announces Collaboration with Novartis on the Discovery and Development of Novel T Cell Receptor Therapies for the Treatment of Solid Tumors
14 Apr 2020 MEI Pharma and Kyowa Kirin Announce Global License, Development and Commercialization Agreement for ME-401
08 Apr 2020 Global COVID-19 Clinical Trial Tracker launched by Cytel
08 Apr 2020 Arrakis Therapeutics Enters Strategic Collaboration and License Agreement with Roche for Multi-Target Program Utilizing RNA-Targeted Small Molecule Drug Discovery Platform
07 Apr 2020 Beam Therapeutics Licenses SIRION Biotech’s LentiBOOST™ Technology for its CAR-T pipeline
06 Apr 2020 Gilead Sciences and Second Genome Announce Strategic Collaboration in Biomarker and Inflammatory Bowel Disease Drug Discovery
04 Apr 2020 Servier signed a definitive agreement to acquire Symphogen, a leading antibody discovery company, to boost its antibody capabilities and leverage its R&D pipeline
04 Apr 2020 panCELLa Extends Exclusive License to Astellas
02 Apr 2020 Kite Licenses Antibodies and Establishes Collaboration With Teneobio in Multiple Myeloma
02 Apr 2020 Horizon Therapeutics plc Acquires Curzion Pharmaceuticals, Inc. and Its LPAR1 Antagonist Product Candidate to Expand Development-Stage Pipeline
02 Apr 2020 Evotec Expands its iPSC-Based Cell Therapy Platform EVOcells Through Licensing Agreement with panCELLa
02 Apr 2020 AC Immune Presents the Latest Preclinical Data on Novel Drug Targets for Neurodegenerative Diseases
01 Apr 2020 Neurimmune and Ethris Sign Collaboration Agreement to Rapidly Develop Inhaled mRNA-based Antibody Therapy for the Treatment of COVID-19
01 Apr 2020 Daiichi Sankyo Enters into Strategic Partnership with Ultragenyx for Use of Gene Therapy Manufacturing Technology
01 Apr 2020 REGENXBIO and Ultragenyx Announce New License Agreement for Use of NAV® Technology Platform for the Treatment of Rare Metabolic Disorder
01 Apr 2020 Lilly and Sitryx Announce Licensing and Research Collaboration to Discover and Develop New Immunometabolic Medicines
27 Mar 2020 CG Oncology Announces License and Commercialization Agreement with Kissei Pharmaceutical Co., Ltd. for CG0070 in Japan and Other Asian Countries
26 Mar 2020 ReCode Therapeutics Raises $80 Million in Oversubscribed Series A Financing

La Merie Biologics

FREE Weekly News Bulletin

Sign Up

2020 Sales ofAntibodies & Proteins

New Product Alert

For La Merie Publishing

Sign Up